Latest Articles

Publication Date
All News Scientific
4 doctor-approved tricks to tackle endometriosis pain without missing a beat at work - Hindustan Times

4 doctor-approved tricks to tackle endometriosis pain without missing a beat at work Hindustan Times

Published: April 21, 2025, 1:38 p.m.
Read Full Article
Pearsanta to begin study of endometriosis test with IRB approval - MSN

Pearsanta to begin study of endometriosis test with IRB approval MSN

Published: April 19, 2025, 1:06 a.m.
Read Full Article
Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer - OncLive

Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer OncLive

Published: April 18, 2025, 3:54 p.m.
Read Full Article
‘Incredibly disappointing’: Period pain education program scrapped - The Mercury

‘Incredibly disappointing’: Period pain education program scrapped The Mercury

Published: April 18, 2025, 7:05 a.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 5:25 a.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - The Malaysian Reserve

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 12:16 a.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Yahoo Finance

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Newswire.ca

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.
Read Full Article
Pearsanta to begin study of endometriosis test with IRB approval - Medical Device Network

Pearsanta to begin study of endometriosis test with IRB approval Medical Device Network

Published: April 17, 2025, 10:54 a.m.
Read Full Article
Factors Influencing Sentinel Node Mapping Failure in Endometrial Cancer - Physician's Weekly

Factors Influencing Sentinel Node Mapping Failure in Endometrial Cancer Physician's Weekly

Published: April 17, 2025, 10:41 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!